Introduction Irritable bowel syndrome (IBS) is a prevalent and debilitating gastrointestinal condition characterized by recurrent flare-ups of symptoms such as increased central pain, bloating, diarrhea, and constipation ( Post-viral gastroenteritis, pre-morbid psychological disorders, and the hypothalamic-pituitary-adrenal axis mediate a maladaptive stress response, which is essential for the onset, intensity, and persistence of IBS-associated symptoms ( The Rome IV diagnostic criteria are currently used to diagnose IBS, which is divided into four subgroups based on bowel habits, bowel function, and stool consistency: constipation dominant (IBS-C), diarrhea dominant (IBS-D), mixed (IBS-M), and unclassified/unspecified IBS (IBS-U) ( Following food consumption, the metabolic endocrine cascade begins with gastric emptying
Both Eli Lilly and Novo Nordisk are competing to bring an oral pill version of a GLP-1 drug to market, as a daily pill could be more accessible and may be more appealing for people who do not want to use weekly GLP-1 injectable medications
Regular Check-Ins: You will come back for follow-up visits
[5] Aim for at least 150 minutes per week of moderate-intensity activity that increases your heart rate, like brisk walking or cycling
